Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

M Wang; S Rule; PL Zinzani; A Goy; O Casasnovas; SD Smith; G Damaj; Jeanette Doorduijn; T Lamy; F Morschhauser; C Panizo; B Shah; A Davies; R Eek; J Dupuis; E Jacobsen; AP Kater; S Le Gouill; L Oberic; T Robak; T Covey; R Dua; A Hamdy; X Huang; R Izumi; P Patel; W Rothbaum; JG Slatter; W Jurczak

doi:10.1016/s0140-6736(17)33108-2

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

M Wang
, S Rule
, PL Zinzani
, A Goy
, O Casasnovas
, SD Smith
, G Damaj
, Jeanette Doorduijn
, T Lamy
, F Morschhauser
, C Panizo
, B Shah
, A Davies
, R Eek
, J Dupuis
, E Jacobsen
, AP Kater
, S Le Gouill
, L Oberic
, T Robak

T Covey, R Dua, A Hamdy, X Huang, R Izumi, P Patel, W Rothbaum, JG Slatter, W Jurczak

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

380 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	659-667
Number of pages	9
Journal	Lancet (UK)
Volume	391
Issue number	10121
DOIs	https://doi.org/10.1016/s0140-6736(17)33108-2
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1016/s0140-6736(17)33108-2

http://hdl.handle.net/1765/110511

Cite this

Wang, M., Rule, S., Zinzani, PL., Goy, A., Casasnovas, O., Smith, SD., Damaj, G., Doorduijn, J., Lamy, T., Morschhauser, F., Panizo, C., Shah, B., Davies, A., Eek, R., Dupuis, J., Jacobsen, E., Kater, AP., Le Gouill, S., Oberic, L., ... Jurczak, W. (2018). Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial. Lancet (UK), 391(10121), 659-667. https://doi.org/10.1016/s0140-6736(17)33108-2

@article{3038e835008546cd9df937fabce7c0a2,

title = "Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial",

author = "M Wang and S Rule and PL Zinzani and A Goy and O Casasnovas and SD Smith and G Damaj and Jeanette Doorduijn and T Lamy and F Morschhauser and C Panizo and B Shah and A Davies and R Eek and J Dupuis and E Jacobsen and AP Kater and \{Le Gouill\}, S and L Oberic and T Robak and T Covey and R Dua and A Hamdy and X Huang and R Izumi and P Patel and W Rothbaum and JG Slatter and W Jurczak",

year = "2018",

doi = "10.1016/s0140-6736(17)33108-2",

language = "Undefined/Unknown",

volume = "391",

pages = "659--667",

journal = "Lancet (UK)",

issn = "0140-6736",

publisher = "Elsevier",

number = "10121",

}

Wang, M, Rule, S, Zinzani, PL, Goy, A, Casasnovas, O, Smith, SD, Damaj, G, Doorduijn, J, Lamy, T, Morschhauser, F, Panizo, C, Shah, B, Davies, A, Eek, R, Dupuis, J, Jacobsen, E, Kater, AP, Le Gouill, S, Oberic, L, Robak, T, Covey, T, Dua, R, Hamdy, A, Huang, X, Izumi, R, Patel, P, Rothbaum, W, Slatter, JG & Jurczak, W 2018, 'Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial', Lancet (UK), vol. 391, no. 10121, pp. 659-667. https://doi.org/10.1016/s0140-6736(17)33108-2

TY - JOUR

T1 - Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

AU - Wang, M

AU - Rule, S

AU - Zinzani, PL

AU - Goy, A

AU - Casasnovas, O

AU - Smith, SD

AU - Damaj, G

AU - Doorduijn, Jeanette

AU - Lamy, T

AU - Morschhauser, F

AU - Panizo, C

AU - Shah, B

AU - Davies, A

AU - Eek, R

AU - Dupuis, J

AU - Jacobsen, E

AU - Kater, AP

AU - Le Gouill, S

AU - Oberic, L

AU - Robak, T

AU - Covey, T

AU - Dua, R

AU - Hamdy, A

AU - Huang, X

AU - Izumi, R

AU - Patel, P

AU - Rothbaum, W

AU - Slatter, JG

AU - Jurczak, W

PY - 2018

Y1 - 2018

U2 - 10.1016/s0140-6736(17)33108-2

DO - 10.1016/s0140-6736(17)33108-2

M3 - Article

SN - 0140-6736

VL - 391

SP - 659

EP - 667

JO - Lancet (UK)

JF - Lancet (UK)

IS - 10121

ER -